Protamine sulfate
DrugBank ID: DB09141
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| CDKL5 disorder | 0.5000 | DL |
| ECHS1-related paroxysmal dyskinesia | 0.5000 | DL |
| EEC syndrome | 0.5000 | DL |
| FOXG1 disorder | 0.5000 | DL |
| MED12-related intellectual disability syndrome | 0.5000 | DL |
| PRPS1 deficiency disorder | 0.5000 | DL |
| Pericytoma with t(7;12) | 0.5000 | DL |
| Rowley-Rosenberg syndrome | 0.5000 | DL |
| TH-deficient infantile parkinsonism and motor delay | 0.5000 | DL |
| acetazolamide-responsive hereditary episodic ataxia | 0.5000 | DL |
| adolescent/adult onset autosomal dominant epilepsy with auditory features | 0.5000 | DL |
| adolescent/adult-onset epilepsy syndrome | 0.5000 | DL |
| adult-onset segmental dystonia | 0.5000 | DL |
| alpha-gal syndrome | 0.5000 | DL |
| anaphylaxis | 0.5000 | DL |
| antibody mediated epilepsy | 0.5000 | DL |
| atypical childhood epilepsy with centrotemporal spikes | 0.5000 | DL |
| autoimmune retinopathy | 0.5000 | DL |
| cerebral folate deficiency | 0.5000 | DL |
| complex neurodevelopmental disorder | 0.5000 | DL |
| ectodermal dysplasia syndrome | 0.5000 | DL |
| epilepsy of infancy with migrating focal seizures | 0.5000 | DL |
| exercise-induced anaphylaxis | 0.5000 | DL |
| febrile seizures plus, genetic epilepsy with febrile seizures plus | 0.5000 | DL |
| food protein-induced allergic proctocolitis | 0.5000 | DL |
| food protein-induced enterocolitis syndrome | 0.5000 | DL |
| food-dependent exercise-induced anaphylaxis | 0.5000 | DL |
| hypereosinophilia of undetermined significance | 0.5000 | DL |
| hypervalinemia and hyperleucine-isoleucinemia | 0.5000 | DL |
| idiopathic anaphylaxis | 0.5000 | DL |
| idiopathic mast cell activation syndrome | 0.5000 | DL |
| immune epilepsy | 0.5000 | DL |
| mast cell activation syndrome | 0.5000 | DL |
| metabolic epilepsy | 0.5000 | DL |
| mixed mineral dust pneumoconiosis | 0.5000 | DL |
| myoclonic encephalopathy in non-progressive disorder | 0.5000 | DL |
| neonatal/infantile epilepsy syndrome | 0.5000 | DL |
| paratenonitis | 0.5000 | DL |
| paratenonitis with tendinosis | 0.5000 | DL |
| photosensitive occipital lobe epilepsy | 0.5000 | DL |
| primary mast cell activation syndrome | 0.5000 | DL |
| rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction | 0.5000 | DL |
| saccharopinuria | 0.5000 | DL |
| secondary mast cell activation syndrome | 0.5000 | DL |
| self-limited familial and non-familial neonatal/infantile seizures | 0.5000 | DL |
| structural epilepsy | 0.5000 | DL |
| tendinopathy | 0.5000 | DL |
| tendinosis | 0.5000 | DL |
| tyrosine hydroxylase deficiency | 0.5000 | DL |
| variable age onset epilepsy | 0.5000 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.